SHA:600535 Revenue

In the year 2025, Tasly Pharmaceutical Group had annual revenue of 8.24B CNY, down -3.08%. Tasly Pharmaceutical Group had revenue of 1.93B in the quarter ending December 31, 2025, a decrease of -5.39%.

Revenue

8.24B

Revenue Growth

-3.08%

P/S Ratio

2.55

Revenue / Employee

751.64K

Employees

10,958

Market Cap

21.02B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.24B	-261.66M	-3.08%
Dec 31, 2024	8.50B	-175.87M	-2.03%
Dec 31, 2023	8.67B	36.58M	0.42%
Dec 31, 2022	8.64B	685.47M	8.62%
Dec 31, 2021	7.95B	-5.62B	-41.43%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jilin Aodong Pharmaceutical Group	2.34B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.25B
Joincare Pharmaceutical Group Industry	15.20B
Apeloa Pharmaceutical Co.,Ltd	10.50B
Wedge Industrial	1.24B
Jiangsu Nhwa Pharmaceutical Co., LTD	6.02B
Dizal (Jiangsu) Pharmaceutical	801.14M
Zhejiang Huahai Pharmaceutical	8.71B

Revenue Rankings